Where to buy Trametinib

Trametinib (Trametinib) has been launched in China and has been included in the medical insurance. This drug may be sold in domestic pharmacies or hospitals. The prices are different for different specifications and manufacturers, but the drug ingredients and efficacy are basically the same. The original drug of Trametinib has also been launched overseas, and there are also generic drugs produced in other countries.

Trametinib is mainly used to treat BRAF V600 mutation-positive malignant melanoma and non-small cell lung cancer. For these patients, trametinib combined with other drugs can improve the treatment effect and prolong progression-free survival and overall survival. Trametinib has also been approved by the U.S. Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic anaplastic thyroid cancer, unresectable or metastatic solid tumors, and low-grade gliomas that are positive for BRAF V600E mutations, but the presence of BRAF V600E or V600K mutations in tumor specimens must be confirmed before starting use.

The domestically marketed trametinib original drug may only be purchased by patients who meet the indications of trametinib, such as BRAF V600 mutation-positive unresectable or metastatic melanoma. Its price is around RMB 10,000-20,000. The reimbursement ratio is different in different regions, and the price is also different, making it expensive. The price of the Turkish version of the original Trametinib drug listed overseas is around RMB 7,900 (the price may fluctuate due to the exchange rate). The price of the generic version of Trametinib produced by Laos pharmaceutical factory is around RMB 2,950 (the price may fluctuate due to the exchange rate). The ingredients and efficacy of foreign generic drugs are basically the same as those of domestic and foreign original drugs.